Chronic granulomatous disease associated with atypical Kawasaki disease

M A Yamazaki-Nakashimada1, N Ramírez-Vargas, J De Rubens-Figueroa

  • 1Department of Clinical Immunology, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C C.P, 04530, Col. Insurgentes Cuicuilco, Mexico City, Mexico. yzki71@yahoo.com.mx

Pediatric Cardiology
|August 7, 2007
PubMed

Insights

Chronic granulomatous disease (CGD) is a rare inherited disorder causing infections and inflammation. A CGD patient presented with Kawasaki Disease-like symptoms, successfully treated with standard therapies.

Area of Science:

  • Immunology
  • Pediatrics
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by impaired phagocyte function, leading to recurrent infections and granuloma formation.
  • Patients with CGD exhibit heightened inflammatory responses and a predisposition to autoimmune conditions.
  • Kawasaki Disease (KD) is an acute febrile vasculitis primarily affecting young children, with potential cardiac complications.

Observation:

  • A 1-year-old boy diagnosed with CGD presented with clinical manifestations suggestive of Kawasaki Disease.
  • The patient exhibited symptoms including prolonged fever, rash, conjunctivitis, and lymphadenopathy, consistent with KD diagnostic criteria.
  • The presence of CGD in a patient with KD raises questions about shared inflammatory pathways or potential disease overlap.

Findings:

  • The patient's presentation mimicked typical Kawasaki Disease, despite the underlying diagnosis of CGD.
  • Treatment with intravenous immunoglobulin (IVIG), aspirin, and corticosteroids resulted in prompt resolution of symptoms.
  • This response suggests that the inflammatory cascade in this CGD patient with KD-like illness shares similarities with that of typical KD.

Implications:

  • This case highlights the potential for overlapping clinical features between CGD and Kawasaki Disease.
  • It underscores the importance of considering standard KD treatments in CGD patients presenting with similar symptoms.
  • Further research may elucidate shared immunopathogenic mechanisms between these distinct conditions.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...